User login
Isolated splenic metastasis in a patient with two distinct genitourinary malignancies
Click on the PDF icon at the top of this introduction to read the full article.
Click on the PDF icon at the top of this introduction to read the full article.
Click on the PDF icon at the top of this introduction to read the full article.
Gemicitabine-induced radiation recall phenomenon in 2 distinctive sites on the same patient
Radiation recall phenomenon is an acute inflammatory reaction that develops in previously irradiated areas after administration of inciting agents systemically. The most common agents are anticancer drugs.1 Gemcitabine, a fluorine-substituted deoxycytidine analog, is widely used as a chemotherapy medication. Its antitumor effect results from the blockade of DNA synthesis and DNA repair. It has been used in advanced pancreatic, non–small-cell lung, bladder, and ovarian cancers; soft-tissue sarcoma; and non-Hodgkin lymphoma.2 It has occasionally been reported to cause radiation recall phenomenon.3 The time between radiation and recall may range from weeks to almost a year.
Click on the PDF icon at the top of this introduction to read the full article.
Radiation recall phenomenon is an acute inflammatory reaction that develops in previously irradiated areas after administration of inciting agents systemically. The most common agents are anticancer drugs.1 Gemcitabine, a fluorine-substituted deoxycytidine analog, is widely used as a chemotherapy medication. Its antitumor effect results from the blockade of DNA synthesis and DNA repair. It has been used in advanced pancreatic, non–small-cell lung, bladder, and ovarian cancers; soft-tissue sarcoma; and non-Hodgkin lymphoma.2 It has occasionally been reported to cause radiation recall phenomenon.3 The time between radiation and recall may range from weeks to almost a year.
Click on the PDF icon at the top of this introduction to read the full article.
Radiation recall phenomenon is an acute inflammatory reaction that develops in previously irradiated areas after administration of inciting agents systemically. The most common agents are anticancer drugs.1 Gemcitabine, a fluorine-substituted deoxycytidine analog, is widely used as a chemotherapy medication. Its antitumor effect results from the blockade of DNA synthesis and DNA repair. It has been used in advanced pancreatic, non–small-cell lung, bladder, and ovarian cancers; soft-tissue sarcoma; and non-Hodgkin lymphoma.2 It has occasionally been reported to cause radiation recall phenomenon.3 The time between radiation and recall may range from weeks to almost a year.
Click on the PDF icon at the top of this introduction to read the full article.